Trials / Unknown
UnknownNCT03122938
Lactoferrin Supplementation and Iron Metabolism in Healthy Pregnant Women
Effect of Daily Bovine Lactoferrin Supplementation on Fetal Development and Iron Metabolism in Healthy Pregnant Women: A Randomized Double-blind Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Beingmate Baby & Child Food Co Ltd . · Academic / Other
- Sex
- Female
- Age
- 20 Years – 34 Years
- Healthy volunteers
- Accepted
Summary
To assess the effects of a lactoferrin supplemented formula on fetal development , iron metabolism and immunity in healthy pregnant women. One hundred and twenty healthy pregnant women (24\<gestational weeks\<26) are enrolled and randomly assigned to lactoferrin-supplemented formula group (active group) or normal formula group (control group, without lactoferrin supplementation). Subjects allocated in active group consume lactoferrin supplemented formula (85mg lactoferrin per 100g) 3 times a day (81g totally), while those in control group consume formula without lactoferrin supplementation (\<6mg lactoferrin per 100g formula) according to the same schedule. Routine blood test including hemoglobin and serum ferritin, and food frequency questionnaire-based review and 24h\*3 dietary record are performed every 4 weeks during intervention until delivery. Body weight of newborns are recorded after delivery. The differences in iron deficiency anemia morbility of pregnant women and anthropometric measurements of newborns between groups would be analyzed after completion of this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | lactoferrin-supplemented formula | Subjects consume lactoferrin-supplemented formula (85mg lactoferrin per 100g) 3 times a day (81g totally). |
| DIETARY_SUPPLEMENT | formula without lactoferrin supplementation | Subjects consume formula without lactoferrin supplementation (\<6mg lactoferrin per 100g formula) 3 times a day (81g totally). |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-04-01
- Completion
- 2017-05-01
- First posted
- 2017-04-21
- Last updated
- 2017-04-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03122938. Inclusion in this directory is not an endorsement.